Daily BriefsSouth Korea

Daily Brief South Korea: LG Chem Ltd, DGB Financial Group, LG Energy Solution, Osstem Implant and more

In today’s briefing:

  • Introducing KODEX Top 5 Plus ETF Rebalancing Event
  • KOSPI 200 Ad Hoc Rebalance for Meritz Securities: DGB Financial Will Be Added
  • ECM Weekly (20th Jan 23) – HK Brokers, Wuxi, IQIYI, Anycol, Adani, WM Mot, LG Ene, AIn, Oasis, Perta
  • KCGI Formally Goes Activist on Osstem Implant

Introducing KODEX Top 5 Plus ETF Rebalancing Event

By Sanghyun Park

  • At this point, one constituent change is expected, and LG Chem is expected to replace KT&G.
  • The return of the equal-weighted long/short basket trade for the constituent changes in the past two years was recorded from 2.3% to 3.8%.
  • Both LG Chem and KT&G are expected to have a significant rebalancing flow impact. It can be an event that brings a juicy day trading return.

KOSPI 200 Ad Hoc Rebalance for Meritz Securities: DGB Financial Will Be Added

By Sanghyun Park

  • With JB Financial Group gone for Meritz Fire, the next one in line will enter KOSPI 200 in place of Meritz Securities. And the lucky one is DGB Financial.
  • DGB can expect an inflow of 8.23x ADTV and will face a 2.8x ADTV in one day on March 31.
  • Given the size of the preemptive flow that JB Financial is currently attracting, we should prepare for DBG to start receiving a similar level of price impact earlier than usual.

ECM Weekly (20th Jan 23) – HK Brokers, Wuxi, IQIYI, Anycol, Adani, WM Mot, LG Ene, AIn, Oasis, Perta

By Sumeet Singh

  • Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
  • Things are starting to pickup on the IPO front with the first somewhat sizeable US ADR filing done this week.
  • Placements deal flow continued to stay strong this week, even as the performance didn’t.

KCGI Formally Goes Activist on Osstem Implant

By Douglas Kim

  • On 20 January, KCGI private equity fund formally started its corporate governance activist campaign on Osstem Implant (048260 KS).
  • KCGI officially going activist on the company, its strong fundamentals and deep discount valuations suggest that Osstem Implant’s price is likely to outperform KOSPI by a wide margin in 2023.
  • KCGI has demanded Kyoo-Ok Choi (Chairman of Osstem Implant) to resign.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars